EGFR and neoplasm: Engineered VV with deletion of the B18R gene is more rapidly cleared from normal tissues while remaining active within tumors; Selectively growth in tumor cells with high levels of cellular thymidine kinase gene; Activated EGFR/Ras pathway signaling